Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24829600 | 0.93 | TYMP (0.31) | TYMP | |
| SCHEMBL24829637 | 0.91 | TYMP (0.32) | TYMP | |
| SCHEMBL24829603 | 0.91 | TYMP (0.36) | TYMP | |
| SCHEMBL24829580 | 0.91 | TYMP (0.32) | TYMP | |
| SCHEMBL27099184 | 0.87 | TYMP (0.31) | TYMP | |
| SCHEMBL13213468 | 0.87 | TYMP (0.34) | TYMP | |
| SCHEMBL10311326 | 0.87 | TYMP (0.30) | TYMP | |
| SCHEMBL17480220 | 0.87 | TYMP (0.30) | TYMP | |
| SCHEMBL31688442 | 0.86 | TYMP (0.30) | TYMP | |
| SCHEMBL13213469 | 0.86 | TYMP (0.32) | TYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542505-B1 | Substituted RIG-I agonists: compositions and methods thereof | MERCK SHARP & DOHME LLC (US) | 2023-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11542505-B1 | Substituted RIG-I agonists: compositions and methods thereof | MAVS, TLR3, DDX18 | TYMP 1375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.